"10.1371_journal.pone.0036713","plos one","2012-05-15T00:00:00Z","Dorothy M French; Benjamin C Lin; Manping Wang; Camellia Adams; Theresa Shek; Kathy Hötzel; Brad Bolon; Ronald Ferrando; Craig Blackmore; Kurt Schroeder; Luis A Rodriguez; Maria Hristopoulos; Rayna Venook; Avi Ashkenazi; Luc R Desnoyers","Department of Pathology, Genentech, Inc., South San Francisco, California, United States of America; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California, United States of America; Department of Antibody Engineering, Genentech, Inc., South San Francisco, California, United States of America; Department of Cancer Signaling and Translational Oncology, Genentech, Inc., South San Francisco, California, United States of America; GEMpath, Inc., Longmont, Colorado, United States of America","Conceived and designed the experiments: DMF BCL MW CA TS KH BB RF CB KS LAR MH RV AA LRD. Performed the experiments: DMF BCL MW CA TS KH BB RF CB KS LAR MH RV LRD. Analyzed the data: DMF BCL MW CA TS KH BB RF CB KS LAR MH RV AA LRD. Contributed reagents/materials/analysis tools: DMF BCL MW CA TS KH BB RF CB KS LAR MH RV LRD. Wrote the paper: DMF BCL MW CA TS KH BB RF CB KS LAR MH RV AA LRD.","The authors have the following competing interest: Dorothy M. French, Benjamin C. Lin, Manping Wang, Camellia Adams, Theresa Shek, Kathy Hötzel, Ronald Ferrando, Craig Blackmore, Kurt Schroeder, Luis A. Rodriguez, Maria Hristopoulos, Rayna Venook, Avi Ashkenazi, and Luc R. Desnoyers were full-time employees of Genentech, Inc. at the time this work was completed. Brad Bolon is a full-time employee of GEMpath, Inc. The affiliations with Genentech, Inc. and GEMpath, Inc. do not alter the authors’ adherence to all PLoS ONE policies on sharing data and materials. A patent is pending for the results described herein.","2012","05","Dorothy M French","DMF",15,TRUE,15,14,15,15,TRUE,TRUE,FALSE,0,NA,FALSE
